Glover M et al. (2009), Renal and brain isoforms of WNK3 have opposite ...

XB-ART-39797

J Am Soc Nephrol 2009 Jun 01;206:1314-22. doi: 10.1681/ASN.2008050542.

Show Gene links Show Anatomy links

Renal and brain isoforms of WNK3 have opposite effects on NCCT expression.

Glover M , Zuber AM , O'Shaughnessy KM .

???displayArticle.abstract???
Mutations in the WNK kinases WNK1 and WNK4 cause a rare familial form of hypertension (Gordon syndrome) by increasing expression of the thiazide-sensitive co-transporter NCCT in the kidney. Regulation of NCCT expression involves a scaffold of proteins composed of several kinases, including the third member of the WNK kinase family, WNK3. This protein, expressed in several tissues including kidney and brain, displays splice variation around exons 18 and 22. We expressed these proteins in Xenopus oocytes and found that the renal isoform of WNK3 increased but the brain isoform decreased NCCT expression and activity. Introduction of a kinase-inactivating mutation into renal WNK3 reversed its action on NCCT, and the same mutation in the brain isoforms led to loss of function. We also studied the effect of phosphorylation of a key NCCT threonine (T58) on the effects of WNK3/4 coexpression; NCCT mutants with a T58A or T58D substitution had the same surface expression as T58 but had significantly altered transporter activity; however, both isoforms of WNK3 as well as WNK4 still modulated expression of these NCCT mutants. Finally, experiments using kinase-dead STE20/SPS1-related proline/alanine-rich kinase (SPAK), a putative downstream target for WNKs, revealed that brain WNK3 acts in tandem with SPAK, whereas renal WNK3 seems to upregulate NCCT through a SPAK-independent pathway. Taken together, these results suggest that the C-terminal motifs contributed by exons 18 and 22 play an important role in the actions of WNK3 isoforms on NCCT.

???displayArticle.pubmedLink??? 19470686
???displayArticle.pmcLink??? PMC2689907
???displayArticle.link??? J Am Soc Nephrol
???displayArticle.grants??? [+]

Species referenced: Xenopus laevis
Genes referenced: slc12a3 slc12a3l stk24 stk39 wnk1 wnk3 wnk4

References [+] :

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). 2002, Pubmed
Cope, WNK1 affects surface expression of the ROMK potassium channel independent of WNK4. 2006, Pubmed , Xenbase
Cope, WNK kinases and the control of blood pressure. 2005, Pubmed , Xenbase
Darman, A regulatory locus of phosphorylation in the N terminus of the Na-K-Cl cotransporter, NKCC1. 2002, Pubmed
de Los Heros, WNK3 bypasses the tonicity requirement for K-Cl cotransporter activation via a phosphatase-dependent pathway. 2006, Pubmed , Xenbase
Gagnon, Volume sensitivity of cation-Cl- cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4. 2006, Pubmed , Xenbase
Gagnon, Apoptosis-associated tyrosine kinase scaffolding of protein phosphatase 1 and SPAK reveals a novel pathway for Na-K-2C1 cotransporter regulation. 2007, Pubmed , Xenbase
Gamba, Molecular cloning, primary structure, and characterization of two members of the mammalian electroneutral sodium-(potassium)-chloride cotransporter family expressed in kidney. 1994, Pubmed , Xenbase
Golbang, A new kindred with pseudohypoaldosteronism type II and a novel mutation (564D>H) in the acidic motif of the WNK4 gene. 2005, Pubmed , Xenbase
Golbang, Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved. 2006, Pubmed , Xenbase
Holden, Cloning, genomic organization, alternative splicing and expression analysis of the human gene WNK3 (PRKWNK3). 2004, Pubmed
Kahle, Molecular physiology of the WNK kinases. 2008, Pubmed
Kahle, WNK3 modulates transport of Cl- in and out of cells: implications for control of cell volume and neuronal excitability. 2005, Pubmed , Xenbase
Lin, Phenotype and genotype analysis in Chinese patients with Gitelman's syndrome. 2005, Pubmed
Moriguchi, WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. 2005, Pubmed
Mount, Splicing a kinase and the regulation of salt transport. 2009, Pubmed
Pacheco-Alvarez, The Na+:Cl- cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion. 2006, Pubmed , Xenbase
Ponce-Coria, Regulation of NKCC2 by a chloride-sensing mechanism involving the WNK3 and SPAK kinases. 2008, Pubmed , Xenbase
Richardson, Activation of the thiazide-sensitive Na+-Cl- cotransporter by the WNK-regulated kinases SPAK and OSR1. 2008, Pubmed
Rinehart, WNK3 kinase is a positive regulator of NKCC2 and NCC, renal cation-Cl- cotransporters required for normal blood pressure homeostasis. 2005, Pubmed , Xenbase
Vitari, The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. 2005, Pubmed
Wang, Domains of WNK1 kinase in the regulation of ROMK1. 2008, Pubmed
Williams, Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. 2004, Pubmed
Wilson, Human hypertension caused by mutations in WNK kinases. 2001, Pubmed
Yang, The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex. 2007, Pubmed , Xenbase